Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 30, 2024Open Access

Data from Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

DPDaniel R. PrincipeMPMary PasquinelliRNRyan H. Nguyen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Principe et al. (2024) studied this question.

synapsesocial.com/papers/68e5a4ccb6db64358753ef0chttps://doi.org/10.1158/2767-9764.c.7425655.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Loss of STK11 Suppresses Lipid Metabolism and Attenuates KRAS-Induced Immunogenicity in Patients with Non-Small Cell Lung Cancer2024 · 10 citations
  2. 2Abstract 7366: Loss of STK11 suppresses lipid metabolism to attenuate KRAS-induced immunogenicity in patients with non-small cell lung cancer2024
  3. 3Figure S3 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024
  4. 4Figure S5 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024
  5. 5Figure S2 from Loss of <i>STK11</i> Suppresses Lipid Metabolism and Attenuates <i>KRAS</i>-Induced Immunogenicity in Patients with Non–Small Cell Lung Cancer2024